snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    B2G/B2B, Drugs Discovery & Development Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (2)

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    391 Startups 23 In the News 28 Recently Updated
    • Total Funding
      $10.59B
      Raised
      546
      Events
    • Private Funding
      $3.63B
      Raised
      331
      Rounds
    • Public Offerings
      $4.86B
      Raised
      183
      Offerings
    • M&A
      $2.1B
      Raised
      32
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Atox Bio logo

    Atox Bio

    PRESUMED INACTIVE
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    2003 B2B 11-50 F $64.85M
    inflammatory-diseases
    infectious-disease
    ischemia
    immunology
    orphan-drug
    therapeutics
    critical-care
    pharmaceuticals
    immunotherapy
    patients
    biotechnology
    healthcare-providers
    Aummune logo

    Aummune

    Individualized Immunotherapy
    2017 B2B 11-50 Seed Undisclosed
    immunotherapy
    cancer
    precision-medicine
    healthcare-providers
    clinics
    personalized-medicine
    treatments
    pharmaceuticals
    cancer-therapy
    AVA Bio Defender logo

    AVA Bio Defender

    Mutation-resistant Viral Defense Technologies
    2007 B2B 1-10 Pre-Funding $0
    pharmaceuticals
    biotechnology
    animal-health
    poultry
    biopharmaceutical
    drug-delivery
    AvoMed logo

    AvoMed

    PRESUMED INACTIVE
    Biowaste-based Bioactive Compound for Dermal Disorders
    2016 B2B 1-10 Seed Undisclosed
    anti-aging
    anti-inflammatory
    natural-active-ingredients
    biotechnology
    healthcare-providers
    medical-technologies
    cosmetic-companies
    skin-care
    cosmetics
    dermatology
    Avraham Pharmaceuticals logo

    Avraham Pharmaceuticals

    PRESUMED INACTIVE
    Prevention of Neurodegenerative Disorders
    2010 B2B 1-10 A $26.2M
    alzheimers-disease
    degenerative-diseases
    neurology
    pharmaceuticals
    pharma-companies
    seniors
    parkinson
    Ayala Pharmaceuticals logo

    Ayala Pharmaceuticals

    Acquired
    Targeted Therapies for People with Rare Cancers
    2017 B2B 11-50 Acquired $102M
    rare-diseases
    cancer
    genomics
    cell-therapy
    drug-discovery
    oncology
    therapeutics
    pharmaceuticals
    life-sciences
    patients
    Ayana Pharma logo

    Ayana Pharma

    Liposomal Drugs for Cancer Treatment
    2012 B2B 11-50 Mature Undisclosed
    cancer
    generic-drugs
    medical-technologies
    drug-delivery
    space-tech
    pharmaceuticals
    hospitals
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    391 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $10.59B
      Raised
      546
      Events
    • Private Funding
      $3.63B
      Raised
      331
      Rounds
    • Public Offerings
      $4.86B
      Raised
      183
      Offerings
    • M&A
      $2.1B
      Raised
      32
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Atox Bio logo
    Raised
    $64.85M
    Atox Bio
    PRESUMED INACTIVE
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    Founded:2003
    Business Model:B2B
    Employees:11-50
    Funding Stage:F
    Aummune logo
    Raised
    Undisclosed
    Aummune
    Individualized Immunotherapy
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:Seed
    AVA Bio Defender logo
    Raised
    $0
    AVA Bio Defender
    Mutation-resistant Viral Defense Technologies
    Founded:2007
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    AvoMed logo
    Raised
    Undisclosed
    AvoMed
    PRESUMED INACTIVE
    Biowaste-based Bioactive Compound for Dermal Disorders
    Founded:2016
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Avraham Pharmaceuticals logo
    Raised
    $26.2M
    Avraham Pharmaceuticals
    PRESUMED INACTIVE
    Prevention of Neurodegenerative Disorders
    Founded:2010
    Business Model:B2B
    Employees:1-10
    Funding Stage:A
    Ayala Pharmaceuticals logo
    Raised
    $102M
    Ayala Pharmaceuticals
    Acquired
    Targeted Therapies for People with Rare Cancers
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    Ayana Pharma logo
    Raised
    Undisclosed
    Ayana Pharma
    Liposomal Drugs for Cancer Treatment
    Founded:2012
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,
    Prev 1 2 3 4 5 6 7 8 Next
    1 2 3 4 5 6 7 8
    Prev Next